Baxalta

1 follower


Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.

Industries

Headquarters

Employees

Links

Org chart

Christophe Weber
President, CEO & Representative Director

Christophe Weber

Collapse
Costa Saroukos
CFO & Director
Takako Ohyabu
Chief Global Corporate Affairs & Sustainability Officer
Mwana Lugogo
Chief Ethics & Compliance Officer
Gabriele Ricci
Chief Data & Technology Officer
Teresa Bitetti
President, Global Oncology Business Unit
Andrew S. Plump
Director & President, Research & Development
Milano Furuta
President, Japan Pharma Business Unit
Julie Kim
President, US Business Unit
Giles Platford
President, Plasma-Derived Therapies Business Unit
Ramona Sequeira
President, Global Portfolio Division
Marcello Agosti
Global Business Development Officer
Yoshihiro Nakagawa
Global General Counsel
Koki Sato
Corporate Strategy Officer & Chief of Staff
Thomas Wozniewski
Global Manufacturing & Supply Officer
Christian Medek
Scientist, Cso, Facility Representative
Allen Harmon
Head Of Quality
Francisco Samir Serralde
Head Of Sales Mexico
Judith Murphy
Sr. Director, External Partnerships
Malin Gillgren Aspehult
Head Of Marketing, Immunology Nordic